Jump to content
RemedySpot.com

Expert Analysis From Norah Terrault, MD, MPH: Updates in HBV Treatment

Rate this topic


Recommended Posts

Posted

OFFICIAL CONFERENCE COVERAGE 2010 Annual Meeting of the American Association for the Study of Liver Diseases

CCO is the official provider of online Conference Coverage of The Liver Meeting® 2010.

To:

CCO member

From:

Norah Terrault, MD, MPHUniversity of California, San FranciscoSan Francisco, California

Subject:

CME-Certified Expert Analysis From AASLD 2010

Click to Access:

Updates in HBV Treatment

While attending the Annual AASLD meeting in Boston, I met with S. F. Lok, MD, and Marcellin, MD, to review some of the most noteworthy new data on HBV treatment. Our discussion is now available on the Clinical Care Options Web site as a CME-certified Expert Analysis. Select topics include:

Study 103: 4 Years of Tenofovir in Patients With HBeAg-Positive Chronic HBV Infection

Study 102: 4 Years of Tenofovir in Patients With HBeAg-Negative Chronic HBV Infection

Prevalence of Proximal Tubular Dysfunction During Tenofovir Therapy for Chronic HBV Infection

NEPTUNE: Peginterferon alfa-2a 90 µg/week vs 180 µg/week for 24 vs 48 Weeks in Patients With HBeAg-Positive HBV Infection

PegBeLiver: Peginterferon alfa-2a for 48 vs 96 Weeks in Patients With HBeAg-Negative Genotype D HBV

Peginterferon alfa-2b for 24 vs 48 Weeks in Patients With HBeAg-Positive HBV Infection

Impact of Mode of Delivery on Perinatal HBV Transmission Risk

Telbivudine Treatment During Late Pregnancy for Prevention of Perinatal HBV Transmission

Incidence and Correlates of Liver Outcomes Among Patients With Chronic HBV Infection

To review this CME-certified Expert Analysis, click here.

This Expert Analysis is located online at:http://clinicaloptions.com/Hepatitis/Conference%20Coverage/AASLD%202010.aspx

Jointly sponsored by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC.

Release date: December 17, 2010Expiration date: December 16, 2011

Supported by educational grants from Bristol-Myers Squibb, Janssen Pharmaceutical Companies of & , Merck, and Vertex.

PARTNERSHIP INFORMATION

CCO is the official provider of online conference coverage of The Liver Meeting® 2010. For more information about the AASLD, go to http://www.aasld.org.

Clinical Care Options Hepatitis

GET MORE FROM CCOHepatitis Slide Library

Review hundreds of slidesets featuring the latest data on hepatitis management. Then download PowerPoint files for use in your own noncommercial talks. Click here to start.

Conference CoverageJournal OptionsManagement SeriesTreatment UpdatesInteractive Cases

Live MeetingsRSS / PodcastsMy CME TrackerFree BookstoreSlide

Downloads

Copyright 2010 Clinical Care Options, LLC. All rights reserved. 1894 Preston White Drive, Suite 110, Reston, VA 20191-5433

To ensure you receive Clinical Care Options educational materials by email,please add info@... to your contacts or address book.

Not a member yet? Click here

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...